Product Information
LORYNA 3 MG-0.02 MG TABLET is a generic product labeled by Xiromed LLC, priced at $0.1895 per EA under NDC 70700011485. Its NADAC has been published 419 times since Aug 15, 2018.
FDA first approved this application on Mar 28, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700011485
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA079221FDA Approved
3/28/2011
TE Code
AB
On Market Since
6/9/2022
Price Statistics
The NADAC for LORYNA 3 MG-0.02 MG TABLET has been published 419 times since Aug 15, 2018, and over the history we have for it it has declined 72.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1895 per EA |
|---|---|
| All-time high | $0.6994 (Aug 15, 2018) |
| All-time low | $0.1278 (Nov 20, 2024) |
| 52-week high | $0.1933 |
| 52-week low | $0.1538 |
| Median price | $0.3304 |
| Average price | $0.3164 |
| Largest weekly change | -32.1% (Nov 20, 2024) |
| Weeks tracked | 419 |
| Tracking since | Aug 15, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Drospirenone and Ethinyl Estradiol Tablets market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORYNA 3 MG-0.02 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORYNA 3 MG-0.02 MG TABLET, manufactured by Xiromed LLC, is $0.1895 per EA (NDC 70700011485), effective Aug 19, 2026.
How has the price of LORYNA 3 MG-0.02 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORYNA 3 MG-0.02 MG TABLET has declined 72.9%. It has been tracked across 419 weekly CMS publications since Aug 15, 2018.
What are the highest and lowest recorded NADAC prices for LORYNA 3 MG-0.02 MG TABLET?
Since Aug 15, 2018, the NADAC for LORYNA 3 MG-0.02 MG TABLET has ranged from a low of $0.1278 (Nov 20, 2024) to a high of $0.6994 (Aug 15, 2018), with a median of $0.3304 per EA.
Are there cheaper alternatives to LORYNA 3 MG-0.02 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of LORYNA 3 MG-0.02 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LORYNA 3 MG-0.02 MG TABLET?
LORYNA 3 MG-0.02 MG TABLET (NDC 70700011485) is labeled by Xiromed LLC, and CMS classifies it as a generic product.